The National Cancer Institute (NCI) is offering this grant to encourage revision applications from currently funded NCI P30 centers. This grant is for expanding original research or accelerating parent study progress by incorporating new technical approaches or instruments, particularly those supported by the NCI Innovative Molecular Analysis Technologies (IMAT) program. These awards aim to incentivize independent validation and accelerate the suitability of emerging IMAT technologies for broader research communities. As a component of the NCI IMAT program, this initiative promotes interdisciplinary collaboration in developing innovative tools and methods crucial for advancing cancer research and scientific discovery.
Opportunity ID: 351181
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-24-015 |
Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 28, 2023 |
Last Updated Date: | Nov 28, 2023 |
Original Closing Date for Applications: | Oct 01, 2024 |
Current Closing Date for Applications: | Oct 01, 2024 |
Archive Date: | Nov 06, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | $150,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | City or township governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Independent school districts Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Special district governments State governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI P30 centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-015.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 351181 Full Announcement-RFA-CA-24-015 -> RFA-CA-24-015-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283926 | Mar 01, 2024 | Oct 01, 2024 | View |
Package 1
Mandatory forms
351181 RR_SF424_5_0-5.0.pdf
351181 PHS398_CoverPageSupplement_5_0-5.0.pdf
351181 RR_OtherProjectInfo_1_4-1.4.pdf
351181 PerformanceSite_4_0-4.0.pdf
351181 RR_KeyPersonExpanded_4_0-4.0.pdf
351181 PHS398_ResearchPlan_5_0-5.0.pdf
351181 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
351181 PHS_Additional_IndirectCosts_2_0-2.0.pdf
351181 PHS_AssignmentRequestForm_3_0-3.0.pdf